1: Jo WT, Kim AY, Woo HG, Song HJ, Baik EJ. Effect of Janus Kinase 3 Inhibitor on Sebaceous Gland Regeneration during Skin Wound Healing. Ann Dermatol. 2023 Aug;35(4):275-284. doi: 10.5021/ad.22.204. PMID: 37550228; PMCID: PMC10407337.
2: Pan L, Peng Z, Zhang R, Zhang R, Liang D, Chen H, Tian H. JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells. Exp Biol Med (Maywood). 2020 Sep;245(15):1395-1403. doi: 10.1177/1535370220942474. Epub 2020 Jul 15. Erratum in: Exp Biol Med (Maywood). 2021 Jan;246(2):NP1. doi: 10.1177/1535370220976078. PMID: 32664806; PMCID: PMC7441354.
3: Güven DC, Orhan C, Şahin K, Uçkun FM. Data-Driven identification of chemopreventive agents for breast cancer. Turk J Med Sci. 2020 Nov 3;50(SI-2):1691-1696. doi: 10.3906/sag-2003-138. PMID: 32233182; PMCID: PMC7672343.
4: Sahin K, Yabas M, Orhan C, Tuzcu M, Sahin TK, Ozercan IH, Qazi S, Uckun FM. Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases. Expert Opin Ther Targets. 2020 Apr;24(4):379-387. doi: 10.1080/14728222.2020.1737014. Epub 2020 Mar 2. PMID: 32106727.
5: Meszaros EC, Malemud CJ. Phosphorylation of STAT proteins by recombinant human IL-6 in immortalized human chondrocyte cell lines, T/C28a2 and C28/I2. J Inflamm Res. 2017 Sep 28;10:143-150. doi: 10.2147/JIR.S93797. PMID: 29026328; PMCID: PMC5627728.
6: Wang YC, Cui XB, Chuang YH, Chen SY. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling. Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1352-1360. doi: 10.1161/ATVBAHA.116.308895. Epub 2017 May 4. PMID: 28473442; PMCID: PMC5503700.
7: Shatrova AN, Mityushova EV, Vassilieva IO, Aksenov ND, Zenin VV, Nikolsky NN, Marakhova II. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes. PLoS One. 2016 Dec 9;11(12):e0167215. doi: 10.1371/journal.pone.0167215. PMID: 27936140; PMCID: PMC5172478.
8: Bhavsar SK, Singh Y, Sharma P, Khairnar V, Hosseinzadeh Z, Zhang S, Palmada M, Sabolic I, Koepsell H, Lang KS, Lang PA, Lang F. Expression of JAK3 Sensitive Na+ Coupled Glucose Carrier SGLT1 in Activated Cytotoxic T Lymphocytes. Cell Physiol Biochem. 2016;39(3):1209-28. doi: 10.1159/000447827. Epub 2016 Sep 5. PMID: 27595398.
9: Shatrova AN, Mityushova EV, Aksenov NV, Marakhova LL. [THE INDUCTION OF CD25 EXPRESSION IN Jurkat T CELLS]. Tsitologiia. 2015;57(5):345-52. Russian. PMID: 26281211.
10: Oh YB, Ahn M, Lee SM, Koh HW, Lee SH, Kim SH, Park BH. Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice. Exp Mol Med. 2013 May 17;45(5):e23. doi: 10.1038/emm.2013.43. PMID: 23680658; PMCID: PMC3674406.
11: Mitiushova EV, Shatrova AN, Zenin VV, Aksenov ND, Marakhova II. [The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes]. Tsitologiia. 2013;55(6):421-9. Russian. PMID: 25509109.
12: Cetkovic-Cvrlje M, Olson M, Ghate K. Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells. Cell Mol Immunol. 2012 Jul;9(4):350-60. doi: 10.1038/cmi.2012.20. Epub 2012 Jun 25. PMID: 22728763; PMCID: PMC4012866.
13: Chiba Y, Goto K, Misawa M. Interleukin-13-induced activation of signal transducer and activator of transcription 6 is mediated by an activation of Janus kinase 1 in cultured human bronchial smooth muscle cells. Pharmacol Rep. 2012;64(2):454-8. doi: 10.1016/s1734-1140(12)70788-0. PMID: 22661199.
14: Lee JE, Lee AS, Kim DH, Jung YJ, Lee S, Park BH, Lee SH, Park SK, Kim W, Kang KP. Janex-1, a JAK3 inhibitor, ameliorates tumor necrosis factor-α-induced expression of cell adhesion molecules and improves myocardial vascular permeability in endotoxemic mice. Int J Mol Med. 2012 May;29(5):864-70. doi: 10.3892/ijmm.2012.920. Epub 2012 Feb 16. PMID: 22344597.
15: Aida Y, Honda K, Tanigawa S, Nakayama G, Matsumura H, Suzuki N, Shimizu O, Takeichi O, Makimura M, Maeno M. IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes. Cell Biol Int. 2012 Apr 1;36(4):367-76. doi: 10.1042/CBI20110150. PMID: 22087578.
16: Shatrova AN, Zenin VV, Aksenov ND, Mitiushova EV, Marakhova II. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. II. The role of interleukin-2]. Tsitologiia. 2011;53(8):652-8. Russian. PMID: 21961284.
17: Zenin VV, Aksenov ND, Shatrova AN, Mitiushova EV, Marakhova II. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. I. The role of JAK and Src tyrosine kinases as revealed by inhibitory analysis]. Tsitologiia. 2011;53(8):645-51. Russian. PMID: 21961283.
18: Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem. 2011;27(5):547-56. doi: 10.1159/000329956. Epub 2011 Jun 15. PMID: 21691072.
19: Batista A, Barata JT, Raderschall E, Sallan SE, Carlesso N, Nadler LM, Cardoso AA. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors. Exp Hematol. 2011 Apr;39(4):457-472.e3. doi: 10.1016/j.exphem.2011.01.005. Epub 2011 Jan 26. PMID: 21277936.
20: Uckun FM, Dibirdik I. Chemoprevention of colorectal cancer by targeting Janus kinase 3 with a rationally designed small molecule inhibitor. Nutr Cancer. 2010;62(7):968-72. doi: 10.1080/01635581.2010.513471. PMID: 20924972.